Multiple analyses have shown that concurrent use of cannabis products with immune checkpoint inhibitors is associated with reduced treatment efficacy.
Lisa Thompson, PharmD, BCOP
Lisa A. Thompson, PharmD, BCOP, Clinical Pharmacy Specialist in Oncology, Kaiser Permanente, Colorado.
